{
    "2019-02-19": [
        [
            {
                "time": "",
                "original_text": "60倍PE 12倍PB 15年长牛的药王恒瑞医药还能走多远？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "PE",
                        "PB",
                        "长牛"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "港股高开低走 恒指收跌0.42%",
                "features": {
                    "keywords": [
                        "港股",
                        "高开低走",
                        "恒指",
                        "收跌"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:国务院新年第一会任务部署,癌症、罕见病产业链将受益",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国务院",
                        "癌症",
                        "罕见病",
                        "产业链",
                        "受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报2019第7期:修复或将持续,提前布局业绩高增长标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "修复",
                        "业绩高增长",
                        "布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}